Variant report
Variant | nsv965727 |
---|---|
Chromosome Location | chr6:56294729-56298343 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:793)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F6 | chr6:56295747-56296528 | H1-hESC | embryonic stem cell: | n/a | chr6:56296182-56296189 chr6:56296182-56296189 chr6:56296182-56296189 |
2 | E2F6 | chr6:56296064-56296277 | K562 | blood: | n/a | chr6:56296182-56296189 chr6:56296182-56296189 chr6:56296182-56296189 |
3 | E2F6 | chr6:56295965-56296393 | H1-hESC | embryonic stem cell: | n/a | chr6:56296182-56296189 chr6:56296182-56296189 chr6:56296182-56296189 |
4 | MAX | chr6:56296068-56296341 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | MAX | chr6:56296007-56296357 | K562 | blood: | n/a | n/a |
6 | MAX | chr6:56295981-56296363 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | MYC | chr6:56295207-56295290 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POLR2A | chr6:56297270-56297326 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr6:56297216-56297231 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr6:56297818-56297829 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr6:56297133-56297143 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr6:56297145-56297270 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr6:56297362-56297392 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr6:56295713-56295791 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr6:56297549-56297673 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr6:56297316-56297328 | MCF-7 | breast: | n/a | n/a |
17 | POLR2A | chr6:56297836-56297854 | MCF-7 | breast: | n/a | n/a |
18 | UBTF | chr6:56296660-56296672 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:56296346-56296396 | Jurkat | blood: | n/a |
2 | chr6:56296129-56296179 | T-47D | breast: | n/a |
3 | chr6:56295593-56295643 | HCF | heart: | n/a |
4 | chr6:56295023-56295073 | BE2_C | brain: | n/a |
5 | chr6:56296240-56296290 | AG09319 | gingival: | n/a |
6 | chr6:56296129-56296179 | HIPEpiC | eye: | n/a |
7 | chr6:56298173-56298223 | T-47D | breast: | n/a |
8 | chr6:56298004-56298054 | CMK | blood: | n/a |
9 | chr6:56296346-56296396 | HRPEpiC | eye: | n/a |
10 | chr6:56296165-56296215 | Jurkat | blood: | n/a |
11 | chr6:56298004-56298054 | Hepatocyte | liver: | n/a |
12 | chr6:56295593-56295643 | Hepatocyte | liver: | n/a |
13 | chr6:56297169-56297219 | RPTEC | kidney: | n/a |
14 | chr6:56298173-56298223 | CMK | blood: | n/a |
15 | chr6:56297263-56297313 | ECC-1 | luminal epithelium: | n/a |
16 | chr6:56296165-56296215 | AG10803 | skin: | n/a |
17 | chr6:56297393-56297443 | SAEC | small airway: | n/a |
18 | chr6:56297169-56297219 | K562 | blood: | n/a |
19 | chr6:56298004-56298054 | HEK293 | kidney: | embryo |
20 | chr6:56295023-56295073 | Hela-S3 | cervix: | n/a |
21 | chr6:56296165-56296215 | ECC-1 | luminal epithelium: | n/a |
22 | chr6:56296240-56296290 | NT2-D1 | testis: | n/a |
23 | chr6:56296240-56296290 | GM12878 | blood: | n/a |
24 | chr6:56296129-56296179 | GM12891 | blood: | n/a |
25 | chr6:56296240-56296290 | AG09309 | skin: | n/a |
26 | chr6:56296129-56296179 | NB4 | blood: | n/a |
27 | chr6:56298004-56298054 | MCF10A-Er-Src | breast: | n/a |
28 | chr6:56295546-56295596 | NT2-D1 | testis: | n/a |
29 | chr6:56298004-56298054 | NB4 | blood: | n/a |
30 | chr6:56297393-56297443 | LNCaP | prostate: | n/a |
31 | chr6:56295629-56295679 | AG04449 | skin: | fetal |
32 | chr6:56296165-56296215 | HCM | heart: | n/a |
33 | chr6:56296165-56296215 | HL-60 | blood: | n/a |
34 | chr6:56297393-56297443 | HL-60 | blood: | n/a |
35 | chr6:56296240-56296290 | SK-N-MC | brain: | n/a |
36 | chr6:56295593-56295643 | ECC-1 | luminal epithelium: | n/a |
37 | chr6:56296240-56296290 | A549 | lung: | n/a |
38 | chr6:56295629-56295679 | HCPEpiC | choroid plexus: | n/a |
39 | chr6:56295629-56295679 | PrEC | prostate: | n/a |
40 | chr6:56297169-56297219 | Hepatocyte | liver: | n/a |
41 | chr6:56295546-56295596 | SKMC | muscle: | n/a |
42 | chr6:56296240-56296290 | NB4 | blood: | n/a |
43 | chr6:56297169-56297219 | NB4 | blood: | n/a |
44 | chr6:56295593-56295643 | GM19239 | blood: | n/a |
45 | chr6:56297169-56297219 | AG04449 | skin: | fetal |
46 | chr6:56295023-56295073 | HL-60 | blood: | n/a |
47 | chr6:56295593-56295643 | MCF-7 | breast: | n/a |
48 | chr6:56297169-56297219 | HEK293 | kidney: | embryo |
49 | chr6:56297169-56297219 | ProgFib | skin: | n/a |
50 | chr6:56295629-56295679 | PFSK-1 | brain: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RCC2P7 | TF binding region |
ENSG00000266793 | TF binding region |
RCC2P7 | CpG island |
ENSG00000266793 | CpG island |
ENSG00000151914 | chromatin interactions |
ENSG00000220666 | chromatin interactions |
ENSG00000266793 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142948606 | chr6:56294807-56294808 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs532561960 | chr6:56294810-56294811 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs150910071 | chr6:56294829-56294830 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs566175331 | chr6:56294850-56294851 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs536787368 | chr6:56294877-56294878 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs548473521 | chr6:56294892-56294893 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs570252205 | chr6:56294924-56294925 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs192222344 | chr6:56294979-56294980 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs537310512 | chr6:56295062-56295063 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs558831278 | chr6:56295076-56295077 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs111285840 | chr6:56295086-56295087 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs368601972 | chr6:56295127-56295128 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs538241007 | chr6:56295130-56295131 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs553389139 | chr6:56295141-56295142 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs139390965 | chr6:56295153-56295154 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs150043975 | chr6:56295194-56295195 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs560893125 | chr6:56295257-56295258 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs576204356 | chr6:56295292-56295293 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs115816081 | chr6:56295297-56295298 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs182334860 | chr6:56295319-56295320 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs144326383 | chr6:56295344-56295345 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs34890211 | chr6:56295349-56295350 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs71549710 | chr6:56295356-56295357 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs547804149 | chr6:56295399-56295400 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs559811936 | chr6:56295531-56295532 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs71560974 | chr6:56295532-56295533 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs594435 | chr6:56295538-56295539 | Inactive region | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs570106998 | chr6:56295565-56295566 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs535021939 | chr6:56295619-56295620 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs607271 | chr6:56295621-56295622 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs531937805 | chr6:56295652-56295653 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs606894 | chr6:56295657-56295658 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs535936003 | chr6:56295677-56295678 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186638283 | chr6:56295705-56295706 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576110040 | chr6:56295749-56295750 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543641386 | chr6:56295799-56295800 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558828694 | chr6:56295835-56295836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs207466995 | chr6:56295944-56295945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112788331 | chr6:56295975-56295976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541357109 | chr6:56296005-56296006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9357918 | chr6:56296009-56296010 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs9475695 | chr6:56296048-56296049 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs201807803 | chr6:56296057-56296058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182388969 | chr6:56296069-56296070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563797888 | chr6:56296102-56296103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530946764 | chr6:56296129-56296130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377282693 | chr6:56296151-56296152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552335183 | chr6:56296155-56296156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34702645 | chr6:56296173-56296174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146830506 | chr6:56296180-56296181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 22522925 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:56295600-56295800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:56295600-56295800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr6:56295800-56297200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:56296800-56297000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr6:56296800-56297000 | Bivalent Enhancer | K562 | blood |
6 | chr6:56296800-56297600 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr6:56297000-56297200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr6:56297000-56297800 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin02 | Skin |
9 | chr6:56297200-56297400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:56297400-56297800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:56297800-56298200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr6:56298000-56298400 | ZNF genes & repeats | Fetal Intestine Large | intestine |